ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Austar Lifesciences Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
2
Flat results in Dec 25
- RAW MATERIAL COST(Y) Grown by 25.96% (YoY)
3
With ROE of 3.62%, it has a Expensive valuation with a 0.44 Price to Book Value
- Over the past year, while the stock has generated a return of 11.11%, its profits have fallen by -28.5%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Industrial Manufacturing)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Austar Lifesciences Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Austar Lifesciences Ltd.
11.11%
0.08
95.63%
Hang Seng Hong Kong
8.76%
0.45
19.63%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.50%
EBIT Growth (5y)
1.52%
EBIT to Interest (avg)
7.29
Debt to EBITDA (avg)
0.73
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
1.67
Tax Ratio
36.40%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.51%
ROE (avg)
9.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.44
EV to EBIT
63.08
EV to EBITDA
8.15
EV to Capital Employed
0.52
EV to Sales
0.34
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.82%
ROE (Latest)
3.62%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 236.71 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 8.17 %
INTEREST COVERAGE RATIO(Q)
Highest at 712.15
CASH AND EQV(HY)
Highest at HKD 307.94 MM
NET SALES(Q)
Highest at HKD 951.09 MM
-1What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 25.96% (YoY
Here's what is working for Austar Lifesciences Ltd.
Interest Coverage Ratio
Highest at 712.15
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Debt-Equity Ratio
Lowest at 8.17 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Cash Flow
Highest at HKD 236.71 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Sales
Highest at HKD 951.09 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Cash and Eqv
Highest at HKD 307.94 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Austar Lifesciences Ltd.
Raw Material Cost
Grown by 25.96% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
